Remarkably, our in vivo experiments showed that the small molecule inhibitor of GATA4–NKX2-5 interaction has beneficial effects on cardiac function and gene expression in several experimental models of myocardial ischemia and pressure overload. The gene discussed is NKX2-5; the disease is myocardial ischemia.